Clinical Trials Browser

Phase EARLY_PHASE1 × Pancreatic Neoplasms × camrelizumab × Clear all

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms